Cargando…

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response

BACKGROUND: Breast cancer is the most frequent cancer in women and consists of a heterogeneous collection of diseases with distinct histopathological, genetic and epigenetic characteristics. In this study, we aimed to identify DNA methylation based biomarkers to distinguish patients with locally adv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dejeux, Emelyne, Rønneberg, Jo Anders, Solvang, Hiroko, Bukholm, Ida, Geisler, Stephanie, Aas, Turid, Gut, Ivo G, Børresen-Dale, Anne-Lise, Lønning, Per Eystein, Kristensen, Vessela N, Tost, Jörg
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861056/ https://www.ncbi.nlm.nih.gov/pubmed/20338046 http://dx.doi.org/10.1186/1476-4598-9-68

Ejemplares similares

Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors
por: Klajic, Jovana, et al.
Publicado: (2013)

Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
por: Muggerud, Aslaug Aa, et al.
Publicado: (2010)

Allele-specific disparity in breast cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2011)

Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer
por: Yoshimura, Noriko, et al.
Publicado: (2004)

Linear and non-linear dependencies between copy number aberrations and mRNA expression reveal distinct molecular pathways in breast cancer
por: Solvang, Hiroko K, et al.
Publicado: (2011)

Genetic polymorphisms in the 5' flanking region of glutathione S-transferase P1 affect promoter methylation
por: Rønneberg, JA, et al.
Publicado: (2005)

Multilocus analysis of SNP and metabolic data within a given pathway
por: Kristensen, Vessela N, et al.
Publicado: (2006)

p16(INK4A) as a predictive factor in patients with locally advanced breast cancer treated with neoadjuvant doxorubicin monotherapy
por: Geisler, S, et al.
Publicado: (2000)

Age, estrogen, and immune response in breast adenocarcinoma and adjacent normal tissue
por: Quigley, David A., et al.
Publicado: (2017)

Heterogeneous DNA Methylation Patterns in the GSTP1 Promoter Lead to Discordant Results between Assay Technologies and Impede Its Implementation as Epigenetic Biomarkers in Breast Cancer
por: Grenaker Alnaes, Grethe I., et al.
Publicado: (2015)

DNA methylation and gene expression patterns in breast cancer progression from in situ carcinoma to invasive carcinoma
por: Fleischer, Thomas, et al.
Publicado: (2013)

Mutations for the people
por: Kristensen, Vessela, et al.
Publicado: (2010)

A systematic comparison of copy number alterations in four types of female cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2016)

Correction to: A systematic comparison of copy number alterations in four types of female cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2018)

GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer
por: Eftang, Lars Lohne, et al.
Publicado: (2016)

Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density
por: Haakensen, Vilde D, et al.
Publicado: (2010)

Data integration from two microarray platforms identifies bi-allelic genetic inactivation of RIC8A in a breast cancer cell line
por: Muggerud, Aslaug Aamodt, et al.
Publicado: (2009)

Gene expression analysis supports tumor threshold over 2.0 cm for T-category breast cancer
por: Solvang, Hiroko K., et al.
Publicado: (2016)

Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers
por: Berge, Elisabet Ognedal, et al.
Publicado: (2010)

Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN
por: Borge, Kaja S., et al.
Publicado: (2015)

Effects of concomitant inactivation of p53 and pRb on response to doxorubicin treatment in breast cancer cell lines
por: Huun, Johanna, et al.
Publicado: (2017)

DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival
por: Fleischer, Thomas, et al.
Publicado: (2016)

Gene Expression Profile Analysis of T1 and T2 Breast Cancer Reveals Different Activation Pathways
por: Riis, Margit L. H., et al.
Publicado: (2013)

Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas
por: Haakensen, Vilde D, et al.
Publicado: (2011)

Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer
por: Akslen, L A, et al.
Publicado: (2011)

TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy
por: Eikesdal, Hans P., et al.
Publicado: (2014)

Evaluation of MetriGenix custom 4D™ arrays applied for detection of breast cancer subtypes
por: Muggerud, Aslaug Aamodt, et al.
Publicado: (2006)

DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival
por: Pedersen, Christine Aaserød, et al.
Publicado: (2022)

Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes
por: Joshi, Himanshu, et al.
Publicado: (2012)

Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer
por: Aure, Miriam Ragle, et al.
Publicado: (2021)

The multitude of molecular analyses in cancer: the opening of Pandora’s box
por: Russnes, Hege G, et al.
Publicado: (2014)

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas.
por: Ellis, P. A., et al.
Publicado: (1997)

Strength and weakness of phase I to IV trials, with an emphasis on translational aspects
por: Lønning, Per Eystein
Publicado: (2008)

Are current development programs realising the full potential of new agents?
por: Lønning, Per Eystein
Publicado: (2010)

Tailored targeted therapy for all: a realistic and worthwhile objective?
por: Lønning, Per Eystein
Publicado: (2009)

Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study
por: Dumeaux, Vanessa, et al.
Publicado: (2008)

Loss of progesterone receptor is associated with distinct tyrosine kinase profiles in breast cancer
por: Tahiri, Andliena, et al.
Publicado: (2020)

Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study
por: Tinholt, Mari, et al.
Publicado: (2014)

Expression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters
por: Baumbusch, Lars O, et al.
Publicado: (2006)

Genome‐wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis
por: Bjaanæs, Maria Moksnes, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r5hc3l4r0qvlh9o8jq8elf0b4b